Neptune Technologies & Bioressources Inc
Neptune Seeks to Develop Medical and Wellness Cannabinoid-based Products
Neptune Technologies & Bioressources Inc. (Laval, QC, Canada) has announced an exclusive research agreement with the purpose of developing new medical and wellness targeted cannabinoid-based products, such as cannabidiol (CBD), combined with krill oil whose combination use would be exclusive to Neptune. The new products will be aimed at the growing number of federal jurisdictions ...
Aker BioMarine and Neptune Close $34 Million Agreement
Neptune Technologies & Bioressources Inc. (Laval, QC, Canada) and Aker BioMarine Antarctic AS (Lysaker, Norway) have announced that they have concluded an agreement whereby Aker BioMarine acquired Neptune’s krill oil inventory and IP for a cash consideration of $34 million (U.S.) paid at closing. “This transaction marks an important step in Neptune’s next phase of development. ...
USPTO Confirms Validity of Certain Neptune Patent Claims
Neptune Technologies & Bioressources Inc. (Laval, QC, Canada) received confirmation on the validity of certain claims on its ‘351 Patent (U.S Patent No. 8,278,351). The positive decision by the Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office (USPTO) triggers the payment of ongoing royalties to Neptune by Aker Biomarine and ...
Neptune’s Production Ramp-up on Target
Neptune Technologies & Bioressources Inc. (Laval, QC Canada) announced that its Sherbrooke plant is now operating at an annualized production capacity of 50 metric tons. “Production levels are on target and we continue to focus on reaching full operating capacity of 150 metric tons of krill oil annually at the end of a three-month ramp-up ...
Don't Miss Out!
Industry Professionals
Stay Informed!
Stay informed about the latest health, nutrition, and wellness developments by signing up for a FREE subscription to Nutrition Industry Executive magazine and digital newsletter.
Once subscribed, you will receive industry insights, product trends, and important news directly to your doorstep and inbox.


